
Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated April 25, 2024, titled " Press Release of the Company for the Fourth Quarter and Year ended March 31, 2024.".
Filed with NSE ·

Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated April 25, 2024, titled " Press Release of the Company for the Fourth Quarter and Year ended March 31, 2024.".
6ix hasn’t read this filing yet.
Alivus Life Sciences Ltd on 6ix
Follow Alivus Life Sciences into a list and get an email when it puts out news.
Follow Alivus Life Sciences